Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2021 | Story Leonie Bolleurs | Photo Supplied
The Department of Engineering Sciences (EnSci) – under the leadership of Dr Abdolhossein Naghizadeh – is heading a collaboration of scientists to create a green concrete that will reduce the impact of cement on the environment.

Conventional cement production is responsible for more than 6% of the overall carbon emissions in the world, which ultimately affects global warming.

The Department of Engineering Sciences (EnSci) at the University of the Free State (UFS) – under the leadership of Dr Abdolhossein Naghizadeh – is heading a collaboration of scientists from universities in South Africa and abroad to create a green concrete that will reduce the impact of cement on the environment.

This product has the potential to be used as an alternative to conventional concrete in large-scale constructions such as residential buildings and infrastructure, as well as small-scale constructions such a pavements and brickworks. 

Dr Nagizadeh, whose passion is cement and green concrete, says the idea of eco-friendly concrete was considered by European researchers a few years ago; however, this technology is still in its initial stages and has not been researched and employed at industrial scale yet. He believes that it is due to the complexity of the preparation process, and the relatively aggressive chemicals used in green concrete mixtures.

Expertise and equipment 

With his knowledge and experience of the product, Dr Naghizadeh – who joined EnSci in 2020 – has been appointed project leader of a collaborative group of scientists from the Universities of Johannesburg, KwaZulu-Natal, Yaoundé in Cameroon, and the Erzurum Technical University in Turkey.  

“Since there are only a limited number of researchers in this field, EnSci is benefiting from the expertise of this international collaboration. The proficiency of this group of scientists are keeping the project current, based on the latest findings in the research area,” says Louis Lagrange, Head of the Department of Engineering Sciences. 

Based on this new capacity, the department decided to establish and equip a new laboratory facility dedicated to cement and concrete research, with a specific current focus on green concrete. 

In this laboratory, they want to create formulations of green concrete, based on user-friendly materials. Furthermore, they aim to simplify the preparation and mixing process. “This can introduce a more eco-friendly, desirable product that can easily be employed extensively in the construction industry,” says Lagrange.

Benefits and other advantages

Besides its ability to reduce the impact on the environment through reduced carbon emissions, the product is also described to perform at equal or even superior strength and durability compared to conventional concrete, with potentially substantial environmental and economic benefits. 

This product is also primarily made from waste materials or industrial by-products. Dr Naghizadeh explains it as follows: “Normal concrete consists of conventional (Portland) cement, sand, stone and water, while in green concrete the conventional cement part of the concrete mix is replaced by industrial wastes or by-products and alkali solutions. These alternative materials are mostly aluminosilicate materials such as fly ash (residue from coal burning process in power plants) and slag (waste material from iron extraction processes).”

“Using these waste substances as binding material in green concrete can, apart from the environmental benefits, also reduce waste and contribute to the circular economy. Annually, more than 36 million tons of fly ash are produced in South Africa alone, of which more than 90% is deposited at landfill sites. Reuse of these waste materials will moderate the related waste deposition issues, such as air and groundwater pollution.”

Production of green concrete

Currently, green concrete is mostly produced in two parts: a solid raw material and an alkali activation solution. With their project, the research group wants to develop green concrete in a powdered form, to be mixed with water, instead of a chemical. Dr Nagizadeh estimates that the construction industry will be able to benefit from their work in about two years’ time when they will have a user-friendly green concrete product ready. 

Apart from putting an eco-friendlier concrete on the market, this project is also establishing a brand-new research niche in the UFS Department of Engineering Sciences. According to Lagrange, this research has the ability to attract postgraduate students and other researchers. He is also looking forward to the international academic recognition that EnSci will receive through published articles in leading international journals, and the participation of researchers in accredited conferences arising from this project. 

Lagrange is pleased that the project is establishing EnSci as a research player of note in the engineering field, specifically in the green engineering field. 

News Archive

Science is diversifying the uses of traditional medicines
2017-07-17

Description: Dr Motlalepula Matsabisa  Tags: traditional medicines, Indigenous Knowledge Systems, Dr Motlalepula Matsabisa, Malaria, priority disease  

Dr Motlalepula Matsabisa.
Photo: Anja Aucamp

According to the World Health Organisation, a large majority of the African population are making use of traditional medicines for health, socio-cultural, and economic purposes. In Africa, up to 80% of the population uses traditional medicines for primary healthcare.

The Indigenous Knowledge Systems (IKS) was identified as a lead programme under the directorship of Dr Motlalepula Matsabisa. Research undertaken by the IKS Lead Programme focuses on some key priority diseases of the country and region – including malaria, HIV, cancer, and diabetes.
 
Not just a plant or tree

Malaria is a priority disease and is prevalent in rural and poor areas, resulting in many traditional health practitioners claiming to treat and cure the disease. There may well be substance to these claims, since as much as 30% of the most effective current prescription medicines are derived from plants.  For instance, chloroquine, artemisinin for malaria, Metformin for diabetes, Vincristine and Vinblastine for cancer, are plant-derived drugs.  

Dr Matsabisa’s current research is investigating a South African medicinal plant that has been shown to have in vitro antiplasmodial activity, with subsequent isolation and characterisation of novel non-symmetrical sesquiterpene lactone compounds offering antimalarial activity. These novel compounds are now patented in South Africa and worldwide. This research is part of the UFS and South Africa’s strive to contribute to the regional and continental malaria problem. The UFS are thus far the only university that has been granted a permit by the Medicines Control Council to undertake research on cannabis and its potential health benefits.

“All of these projects are aimed
at adding value through the scientific
research of medicinal plants, which
can be used for treating illnesses,
diseases, and ailments.”

Recognition well deservedThrough Dr Matsabisa’s research input and contributions to the development of the pharmacology of traditional medicines, he recently became the first recipient of the International Prof Tuhinadrin Sen Award from the International Society of Ethnopharmacology (ISE) and the Society of Ethnopharmacology in India. ISE recognises outstanding contributions by researchers, scientists, and technologists in the area of medicinal plant research and ethnopharmacology internationally.

More recently, Dr Matsabisa undertook research projects funded by the National Research Foundation, as well as the Department of Science and Technology, on cancer, gangrene, and diabetes. He is also involved in a community project to develop indigenous teas with the community. He says, “All of these projects are aimed at adding value through the scientific research of medicinal plants, which can be used for treating illnesses, diseases, and ailments”.

Dr Matsabisa has worked with many local and international scientists on a number of research endeavours. He is grateful to his colleagues from the Department of Pharmacology in the Faculty of Health Sciences, who are dedicated to science research and the research of traditional medicines. The IKS unit also received immense support from the Directorate of Research Development.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept